Now showing items 1-2 of 2

    • Intravenous iron therapy and the cardiovascular system: risks and benefits 

      Del Vecchio, Lucia; Ekart, Robert; Charles J. Ferro; Malyszko, Jolanta; Mark, Patrick B.; Ortiz, Alberto; Sarafidis, Pantelis; Valdivielso Revilla, José Manuel; Mallamaci, Francesca (European Renal Association - European Dialysis and Transplant Association (ERA-EDTA); Oxford University Press, 2021)
      Anaemia is a common complication of chronic kidney disease (CKD). In this setting, iron deficiency is frequent because of the combination of increased iron needs to sustain erythropoiesis with increased iron losses. Over ...
    • Lipid management in patients with chronic kidney disease 

      Ferro, Charles J.; Mark, Patrick B.; Kanbay, Mehmet; Sarafidis, Pantelis; Heine, Gunnar H.; Rossignol, Patrick; Massy, Ziad A.; Mallamaci, Francesca; Valdivielso Revilla, José Manuel; Malyszko, Jolanta; Verhaar, Marianne C.; Ekart, Robert; Vanholder, Raymond; London, Gerard; Ortiz, Alberto; Zoccali, Carmine (Nature Research, 2018)
      An increased risk of cardiovascular disease, independent of conventional risk factors, is present even at minor levels of renal impairment and is highest in patients with end-stage renal disease (ESRD) requiring dialysis. ...